Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children

Published:2017 Issue:5 Volume:60 Page:151
ISSN:1738-1061
Container-title:Korean Journal of Pediatrics
language:en
Short-container-title:Korean J Pediatr

Author:

Lee Eun¹,Cho Hyun-Ju²,Hong Soo-Jong²,Lee Jina²,Sung Heungsup³,Yu Jinho²

Affiliation:

1. Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea.

2. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

3. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Ministry of Science, ICT and Future Planning

Publisher

Korean Pediatric Society

Subject

Pediatrics,Pediatrics, Perinatology and Child Health

Link

https://synapse.koreamed.org/pdf/10.3345/kjp.2017.60.5.151

Reference25 articles.

1. Mycoplasma pneumoniae in Korean children: The epidemiology of pneumonia over an 18-year period

2. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children

3. Macrolide Therapy in Chronic Inflammatory Diseases

4. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae

5. Macrolide Resistance ofMycoplasma pneumoniae,South Korea, 2000–2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children;World Journal of Pediatrics;2024-08-14

2. Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic;Virology Journal;2024-08-11

3. Clinical Features and Associated Factors of Macrolide-Unresponsive Mycoplasma pneumonia and Efficacy Comparison Between Doxycycline, Tosufloxacin and Corticostreoid as a Second-Line Treatment;Pediatric Infection & Vaccine;2024

4. Comparison of the characteristics of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae pneumonia requiring hospitalization in children;Allergy, Asthma & Respiratory Disease;2023

5. Macrolide resistant Mycoplasma pneumonia: where we come from, where we are, and where do we go from here?;Allergy, Asthma & Respiratory Disease;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3